Credit Suisse Downgrades Spectrum Pharmaceuticals (SPPI) to Underperform
Credit Suisse downgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Neutral to Underperform.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here. Shares of Spectrum Pharmaceuticals closed at $8.01 yesterday, with a 52 week range of $6.92-$17.48.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here begin ad tag (tile=12) -- End ad tag --